日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma

新辅助免疫疗法中反应适应性手术时机可增强头颈部鳞状细胞癌的病理治疗反应

Mastrolonardo, Eric V; Nunes, Kathryn L; Llerena, Pablo; Nikitina, Anastasia; Sobol, Anastasia; Scott, E Reilly; Tuluc, Madalina; Davitt, Christopher J H; Scher, Jessica; Tekumalla, Sruti; Mann, Derek; Henao, Camilo; Jegede, Victor; Gargano, Stacey; Harshyne, Larry A; Alnemri, Angela; Tyshevich, Andrey; Kushnarev, Vladimir; Chasse, Madison; Sookiasian, Danielle; Axelrod, Rita; Zhan, Tingting; Leiby, Benjamin E; Old, Matthew; Seim, Nolan; Mahoney, My G; Martinez-Outschoorn, Ubaldo; Cognetti, David M; Curry, Joseph M; Prendergast, George C; Argiris, Athanassios; South, Andrew P; Linnenbach, Alban J; Johnson, Jennifer M; Luginbuhl, Adam J

Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC

细胞外基质-MYCAF 特征与 HPV 阳性头颈部鳞状细胞癌患者对新辅助 PD-L1 免疫检查点抑制剂度伐利尤单抗联合二甲双胍治疗的耐药性相关

Llerena, Pablo; Samarah, Hani; Nunes, Kathryn; Lin, Zhao; Bridgham, Kelly; Tekumalla, Sruti; Jain, Amiti; Harshyne, Larry; Shukla, Sanket K; Vathiotis, Ioannis; Tuluc, Madalina; Gargano, Stacey; Eisenbrey, John R; Keith, Scott; Cognetti, David M; Bar-Ad, Voichita C; Luginbuhl, Adam J; Axelrod, Rita; Vadigepalli, Rajanikanth; Yang, Hushan; Whitaker-Menezes, Diana; Roche, Megan; Mahoney, My G; Argiris, Athanassios; Solomides, Charalambos; Johnson, Jennifer M; Barbirou, Mouadh; Miller, Amanda; South, Andrew P; Mitra, Ramkrishna; Linnenbach, Alban J; Martinez-Outschoorn, Ubaldo; Curry, Joseph M

Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

基因表达亚型与接受纳武利尤单抗治疗的复发/转移性头颈部鳞状细胞癌患者的预后和治疗反应之间的关联

Serafini, Mara Serena; Cavalieri, Stefano; Licitra, Lisa; Pistore, Federico; Lenoci, Deborah; Canevari, Silvana; Airoldi, Mario; Cossu Rocca, Maria; Strojan, Primoz; Kuhar, Cvetka Grasic; Merlano, Marco; Perrone, Federica; Vingiani, Andrea; Denaro, Nerina; Perri, Francesco; Argiris, Athanassios; Gurizzan, Cristina; Ghi, Maria Grazia; Cassano, Alessandra; Allegrini, Giacomo; Bossi, Paolo; De Cecco, Loris

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305

针对接受化疗的复发或转移性头颈癌患者的新预后模型:ECOG-ACRIN E1305 分析

Argiris, Athanassios; Flamand, Yael; Savvides, Panayiotis; Johnson, Jennifer M; Vathiotis, Ioannis; Levine, Marshall; Li, Shuli; Forastiere, Arlene A; Burtness, Barbara

Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma

新辅助免疫检查点抑制剂治疗头颈部鳞状细胞癌试验中免疫相关不良事件和细胞因子谱的预测能力

Alnemri, Angela E; Tekumalla, Sruti; Moroco, Annie E; Vathiotis, Ioannis; Tuluc, Madalina; Gargano, Stacey; Zhan, Tingting; Cognetti, David M; Curry, Joseph M; Argiris, Athanassios; Linnenbach, Alban; South, Andrew P; Harshyne, Larry A; Johnson, Jennifer M; Luginbuhl, Adam J

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

纳武利尤单抗联合伊匹木单抗对比 EXTREME 方案作为复发/转移性头颈部鳞状细胞癌一线治疗:CheckMate 651 研究的最终结果

Haddad, Robert I; Harrington, Kevin; Tahara, Makoto; Ferris, Robert L; Gillison, Maura; Fayette, Jerome; Daste, Amaury; Koralewski, Piotr; Zurawski, Bogdan; Taberna, Miren; Saba, Nabil F; Mak, Milena; Kawecki, Andrzej; Girotto, Gustavo; Alvarez Avitia, Miguel Angel; Even, Caroline; Toledo, Joaquin Gabriel Reinoso; Guminski, Alexander; Müller-Richter, Urs; Kiyota, Naomi; Roberts, Mustimbo; Khan, Tariq Aziz; Miller-Moslin, Karen; Wei, Li; Argiris, Athanassios

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era

靶向治疗头颈部鳞状细胞癌的血管生成:免疫治疗时代的机遇

Saba, Nabil F; Vijayvargiya, Pooja; Vermorken, Jan B; Rodrigo, Juan P; Willems, Stefan M; Zidar, Nina; de Bree, Remco; Mäkitie, Antti; Wolf, Greg T; Argiris, Athanassios; Teng, Yong; Ferlito, Alfio

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

头颈癌化疗荟萃分析(MACH-NC):107项随机试验和19805例患者的最新进展,代表MACH-NC研究组

Lacas, Benjamin; Carmel, Alexandra; Landais, Cécile; Wong, Stuart J; Licitra, Lisa; Tobias, Jeffrey S; Burtness, Barbara; Ghi, Maria Grazia; Cohen, Ezra E W; Grau, Cai; Wolf, Gregory; Hitt, Ricardo; Corvò, Renzo; Budach, Volker; Kumar, Shaleen; Laskar, Sarbani Ghosh; Mazeron, Jean-Jacques; Zhong, Lai-Ping; Dobrowsky, Werner; Ghadjar, Pirus; Fallai, Carlo; Zakotnik, Branko; Sharma, Atul; Bensadoun, René-Jean; Ruo Redda, Maria Grazia; Racadot, Séverine; Fountzilas, George; Brizel, David; Rovea, Paolo; Argiris, Athanassios; Nagy, Zoltán Takácsi; Lee, Ju-Whei; Fortpied, Catherine; Harris, Jonathan; Bourhis, Jean; Aupérin, Anne; Blanchard, Pierre; Pignon, Jean-Pierre

Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer

口腔癌多学科综合治疗中的术前免疫疗法

Philips, Ramez; Han, Chihun; Swendseid, Brian; Curry, Joseph; Argiris, Athanassios; Luginbuhl, Adam; Johnson, Jennifer

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)

一项剂量探索研究,随后开展一项 II 期随机、安慰剂对照试验,研究在 III 期非小细胞肺癌中使用或不使用 Veliparib 进行放化疗的效果:SWOG 1206 (8811)

Argiris, Athanassios; Miao, Jieling; Cristea, Mihaela C; Chen, Allen M; Sands, Jacob M; Decker, Roy H; Gettinger, Scott N; Daly, Megan E; Faller, Bryan A; Albain, Kathy S; Yanagihara, Ronald H; Garland, Linda L; Byers, Lauren A; Wang, Ding; Koczywas, Marianna; Redman, Mary W; Kelly, Karen; Gandara, David R